Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_000352.6(ABCC8):āc.2666A>Cā(p.Lys889Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
Uncertain significance, criteria provided, single submitter
clinical testing
Counsyl
Jun 07, 2018
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Dec 19, 2024
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Apr 27, 2017
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Jan 21, 2021
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Dec 29, 2021
Variant summary: ABCC8 c.2666A>C (p.Lys889Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251466 control chromosomes. c.2666A>C has been reported in the literature in a patient with diazoxide-unresponsive diffuse CHI carrying only the variant of interest (Bellanne-Chantelot_2010), as well as a patient with CHI carrying the variant in the homozygous state (Giurgea_2004). These data indicate that the variant may be associated with disease. In vitro expression studies testing traffic efficiency and responses of mutant channels to activation by MgADP and diazoxide showed the variant to have reduced but significant activity (Saint-Martin_2015). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Type 2 diabetes mellitus Pathogenic:1
Likely pathogenic, criteria provided, single submitter
clinical testing
Baylor Genetics
Mar 13, 2024
- -
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter
research
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Oct 26, 2018
ACMG criteria: PP3 (REVEL 0.763 + 8 predictors; not using BP4/2 predictors), PM2 (extremely low frequency in gnomAD)= VUS (Not using PS3- PMID:24814349/Saint Martin 2015 paper, it seems the functional studies aren't completely conclusive- it shows limited effect on channel activity (50% of WT compared to other mutations that maintained less than 85% of WT activity; "The K890T channel showed ~50% and ~70% of the WT response to MgADP and diazoxide, respectively, consistent with the reduced but significant activity in Rb efflux assays." Two cases PMID: 14764815 and PMID: 24814349 but not sure if phenotype is specific so not using PP4) -
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Apr 27, 2017
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Permanent neonatal diabetes mellitus Uncertain:1
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Apr 27, 2017
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -